stock
AMRX · Amneal Pharmaceuticals, Inc.
What Amneal Pharmaceuticals, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live AMRX price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on AMRX.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 319,353,919 as of 2026-07-31 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- 39.3%
- Operating
- 14.6%
- Net
- 5.0%
Returns
- ROE
- 476.5%
- ROA
- 4.2%
Health
- Current ratio
- 2.2x
- Debt/equity
- 77.8x
Deep value
- NCAV
- —
- NCAV per share
- —
- Price/NCAV
- Locked
- NNWC
- —
- NNWC per share
- —
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $796.20M | $334.51M | $129.77M | $57.66M | 10-Q filed 2026-08-06 |
| 2026-03-31 | $722.52M | $320.11M | $141.77M | $62.26M | 10-Q filed 2026-05-07 |
| 2025-12-31 | $814.32M | $297.19M | $112.03M | $35.08M | 10-K filed 2026-02-27 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | $784.51M | $273.97M | $70.34M | $2.37M | 10-Q filed 2025-11-06 |
| 2025-06-30 | $724.51M | $286.25M | $111.37M | $22.42M | 10-Q filed 2026-08-06 |
| 2025-03-31 | $695.42M | $255.89M | $100.35M | $12.20M | 10-Q filed 2026-05-07 |
| 2024-12-31 | $730.52M | $262.87M | $75.79M | -$31.08M | 10-K filed 2026-02-27 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | $702.47M | $269.56M | $88.81M | -$156,000 | 10-Q filed 2025-11-06 |
- Assets
- $3.78B
- Equity
- $33.02M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $3.02B | $394.10M | $72.06M | $269.93M |
| 2024-12-31 | $2.79B | $249.33M | -$116.89M | $243.18M |
| 2023-12-31 | $2.39B | $204.37M | -$83.99M | $302.36M |
| 2022-12-31 | $2.21B | -$94.93M | -$270.58M | $18.69M |
| 2021-12-31 | $2.09B | $152.72M | $13.16M | $194.09M |
| 2020-12-31 | $1.99B | $91.16M | $67.79M | $322.56M |
| 2019-12-31 | $1.63B | -$248.68M | -$603.57M | -$45.48M |
| 2018-12-31 | $1.66B | -$19.67M | -$19.74M | $167.14M |
| 2017-12-31 | $1.03B | $245.10M | $0 | $139.42M |
| 2016-12-31 | $1.02B | $284.88M | $0 | -$7.70M |
Company filings
since Thu Sep 3
events
Material agreement, Acquisition or sale completed, New debt, Unregistered share sale, Regulation FD disclosure
Material agreementAcquisition or sale completedNew debtUnregistered share saleRegulation FD disclosureAug 108-KMaterial agreement
Material agreementAug 38-KShareholder vote results
Shareholder vote resultsJul 318-KResults, Regulation FD disclosure
ResultsRegulation FD disclosureJul 308-KShareholder vote results
Shareholder vote resultsMay 78-KResults
ResultsMay 78-K
5% owners ()
Tushar Patel
Stake update
Chirag Patel
Stake update
Chintu Patel
Stake update
BlackRock, Inc.
Passive stake
Patel Dipan
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Kiely John
Director
Sale$882,000Aug 14, 4:29 PM ET
Shah Nikita
Executive Vice President
Sale$2,563,517Aug 13, 4:22 PM ET
Daly Jason B.
EVP, Chief Legal Officer
Sale$3,771,050Aug 13, 4:21 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named AMRX, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about AMRX.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on AMRX come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the AMRX board